Table 2.
Predicted target genes along with their associated GO terms enriched
| Gene | GO ID | Biological process |
|---|---|---|
| SHPRH, RSF1, MLL, NAP1L1, WRN, MLH3, SIRT1, TAF5L, HUWE1, BRPF3, SUPT16H, PHF21A, KDM3B, PARP1, USP16, MYSM1, RERE, EP400, APC | 0051276 | Chromosome organization |
| TAF5L, HUWE1, BRPF3, USP16, SIRT1, MYSM1, EP400 | 0016570 | Histone modification |
| TAF5L, MLL, RSF1, HUWE1, BRPF3, PHF21A, KDM3B, USP16, SIRT1, MYSM1, EP400, RERE | 0016568 | Chromatin modification |
| TAF5L, HUWE1, BRPF3, USP16, SIRT1, MYSM1, EP400 | 0016569 | Covalent chromatin modification |
| SHPRH, RSF1, MLL, NAP1L1, SIRT1, TAF5L, BRPF3, HUWE1, SUPT16H, PHF21A, KDM3B, USP16, RERE, EP400, MYSM1 | 0006325 | Chromatin organization |
| UHRF2, ZAK, SMAD3, PPP1CB, PTPN11, APC | 0051726 | Regulation of cell cycle |
| BCAT1, TAF1, MLL, ZAK, SMAD3, MLH3, PPP1CB, TACC1, JMY, CUL5, PSMC6, UHRF2, HSPA2, CASP8AP2, MAPK4, PTP4A1, TUBE1, TNKS, MAPRE2, MAPRE1, USP16, DST, APC | 0007049 | Cell cycle |
| BCAT1, TAF1, ZAK, SMAD3, MLH3, PPP1CB, JMY, CUL5, PSMC6, HSPA2, TUBE1, MAPRE2, TNKS, MAPRE1, USP16, DST, APC | 0022402 | Cell cycle process |
| BCAT1, CUL5, PPP1CB | 0000082 | G1/S transition of mitotic cell cycle |
| BCAT1, TAF1, CUL5, PPP1CB | 0051329 | Interphase of mitotic cell cycle |
| BCAT1, TAF1, CUL5, PPP1CB | 0051325 | Interphase |
| BCAT1, TAF1, PSMC6, CUL5, TNKS, MAPRE2, MAPRE1, USP16, PPP1CB, APC | 0000278 | Mitotic cell cycle |
| BCAT1, TAF1, CUL5, HSPA2, TNKS, MAPRE2, MAPRE1, MLH3, USP16, PPP1CB, APC | 0022403 | Cell cycle phase |
| TNIK, ZAK, MAPK8IP1 | 0031098 | Stress-activated protein kinase signaling pathway |
| PHIP, UTP11L, EPHA7, GRB10, BAIAP2, SOCS7, RAF1, SOCS5, PTPN11 | 0007169 | Transmembrane receptor protein tyrosine kinase signaling pathway |
| TWSG1, SMAD9, ID1, SMAD5, SMAD3 | 0007178 | Transmembrane receptor protein serine/threonine kinase signaling pathway |